Overview
Leaderna Biostructures provides end-to-end Gene-to-Structure services for drug discovery projects at pharmaceutical and biotechnology companies. Its work includes expression construct preparation and recombinant protein production, X-ray crystallography, cryo-electron microscopy, and biophysical and biochemical assays, including analysis of protein complexes with nucleic acid-based drugs.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 53 days early.
- 202522/06/2026
- 202424/06/2025
- 202321/06/2024
- 202222/06/2023
- 202123/06/2022
- 202025/03/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Offer
- Expression construct preparation
- Recombinant protein production
- X-ray crystallography
- Cryo-EM analysis
- Biochemical assays
- Biophysical assays
- Protein complex crystallization
Website technology
- Website
- WordPress
Authorized Representatives
Manner of representation
In the event that the management board is multi-member, each member of the management board is independently authorised to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sylwester Pobiarzynage 42 | 100 | $1,350.62 | 50% |
Przemysław Paweł Putnoage 39 | 100 | $1,350.62 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2020-02-19 to 2026-02-05.
Reason for removal: Art. 96 ust. 9 pkt 4 (taxpayer or their representative fails to appear on summons of tax authorities)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $20,552.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 28, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $9,851$9,851 | Fundacja Klaster Lifescience Kraków | |
| Feb 28, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $608$608 | Fundacja Klaster Lifescience Kraków | |
| Mar 2, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $5,046$5,046 | Fundacja Innowacyjna Polska |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biofarmsp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Sciencepharmasp. z o.o. | $111,783,976.52 | sciencepharma.com | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $40,633,950.51 | biomed.pl | ||
| Biofaktorsp. z o.o. | $10,761,755.73 | biofaktor.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Human BiomeS.A. | $583,508.16 | human-biome.com | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| BIO Animalisp. z o.o. | $48,959.05 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-09 | Address change (Ul. Żwirki I Wigury 101, 02-089, Warszawa → Ul. Targ Rybny 11/2, 80-838, Gdańsk) | |
| 2025-09-09 | Switch to PKD 2025 (9 PKD 2007 codes → 9 PKD 2025 codes) | |
| 2020-02-26 | Entered in the register |
FAQ
Last updated: 2026-06-22